Pathway to the Clinic featuring Drs. Irion & Tabar | The Stem Cell Podcast

In episode 255 of the Stem Cell Podcast, we chat with Dr. Stefan Irion, Chief Scientific Officer of BlueRock Therapeutics, and Dr. Viviane Tabar, Chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center. In this special episode, recorded in front of a live audience in New York, they talk about their work on BlueRock’s clinical trial for bemdaneprocel — a stem cell-derived investigational cell therapy for Parkinson’s disease. They also discuss what’s next for cell therapy and diversity in science and in patients.

Subscribe today to never miss an episode!
Listen on iTunes: https://apple.co/2T8BhPA
Listen on Stitcher: https://bit.ly/3hGwsGA
Listen on Spotify: https://spoti.fi/3xFdENP
Official Website: https://stemcellpodcast.com/
Enjoy the other episodes in our full series playlist here: https://bit.ly/3HdhWzW

Find the podcast on social media!
Follow us on Twitter: https://bit.ly/3pbfC65
Like us on Facebook: https://bit.ly/3LOu1Po
Follow us on LinkedIn: https://bit.ly/3IeRCXb
This podcast is brought to you by STEMCELL Technologies!